Anouchka Vidal is the Global/EU HTA Pipeline Lead at Roche, a position held since 2023. Previously, they served as Access Evidence Lead, where they ensured HTA and payer evidence requirements were integrated into product development plans. Anouchka has extensive experience in the healthcare sector, having worked as an International HTA Intelligence and Payer Strategy Manager at Sanofi-Aventis, and as a Payer Engagement and Policy Lead at Sanofi. Their educational background includes an MBA in strategy and project management from IAE Montpellier and a Doctor of Pharmacy from the University of Pharmacy in Toulouse. Anouchka is currently enhancing their leadership skills through the AccessLeaders@Roche program.
This person is not in the org chart
This person is not in any teams
This person is not in any offices